TGA Approval To Commercially Manufacture Stem Cell Products
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
Later from Mesoblast
- Key Bone Repair Patent Granted in the United States
- Market Exclusivity Strengthened by New USA Healthcare Act
- MSB partner jcr files for product approval
- Mesoblast Cells Show Disease Modifying Effects on Knee OA
- Mesoblast Provides Q3 Financial Results and Corporate Update
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast